Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue	Net income	Net margin ▴	Return on equity	Revenue growth	Diluted EPS
RGNX	REGENXBIO Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.44M	-$193.88M	-113.8%	-188.7%	104.5%	-$3.76
ZEOX	Zeo ScientifiX, Inc. Manufacturing · Year ended 2025-10-31 · USD	$5.20M	-$5.52M	-106.2%	n/a	12.5%	-$0.86
IVVD	Invivyd, Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.43M	-$52.49M	-98.2%	-21.7%	110.5%	-$0.30
CRIS	Curis Inc Manufacturing · Year ended 2025-12-31 · USD	$9.44M	-$7.58M	-80.3%	-138.8%	-13.4%	-$0.58
BEAM	Beam Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$139.74M	-$79.99M	-57.2%	-6.5%	120.0%	-$0.81
GLUE	Monte Rosa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$123.67M	-$38.63M	-31.2%	-16.6%	63.5%	n/a
FENC	Fennec Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.64M	-$9.74M	-21.8%	-27.5%	-6.1%	-$0.34
ADPT	Adaptive Biotechnologies Corp Manufacturing · Year ended 2025-12-31 · USD	$276.98M	-$59.50M	-21.5%	-27.2%	54.8%	-$0.39
TWST	Twist Bioscience Corp Manufacturing · Year ended 2025-09-30 · USD	$376.57M	-$77.67M	-20.6%	-16.4%	20.3%	-$1.30
TARS	Tarsus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$451.36M	-$66.42M	-14.7%	-19.3%	146.7%	-$1.59
PLX	Protalix BioTherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$52.74M	-$6.60M	-12.5%	-13.7%	-1.2%	-$0.08
IMCR	Immunocore Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$400.02M	-$35.51M	-8.9%	-9.3%	29.0%	-$0.71
IPSC	Century Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$109.16M	-$9.58M	-8.8%	-6.0%	n/m	-$0.14
AGEN	Agenus Inc Manufacturing · Year ended 2025-12-31 · USD	$114.20M	-$3.08M	-2.7%	n/a	10.4%	$0.00
CSBR	Champions Oncology, Inc. Manufacturing · Year ended 2026-04-30 · USD	$59.42M	-$1.18M	-2.0%	-29.8%	4.4%	-$0.08
VCEL	Vericel Corp Manufacturing · Year ended 2025-12-31 · USD	$276.26M	$16.52M	6.0%	4.7%	16.5%	$0.32
RGEN	Repligen Corp Manufacturing · Year ended 2025-12-31 · USD	$738.26M	$48.89M	6.6%	2.3%	16.4%	$0.86
VXRT	Vaxart, Inc. Manufacturing · Year ended 2025-12-31 · USD	$237.26M	$16.33M	6.9%	18.6%	726.7%	$0.07
BIIB	Biogen Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.89B	$1.29B	13.1%	7.1%	2.2%	$8.79
TECH	Bio-Techne Corp Manufacturing · Year ended 2026-06-30 · USD	$1.22B	$181.86M	15.0%	8.6%	-0.4%	$1.16
NBIX	Neurocrine Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$2.86B	$478.60M	16.7%	14.7%	21.4%	$4.67
QGEN	Qiagen N.V. Manufacturing · Year ended 2025-12-31 · USD	$2.09B	$424.88M	20.3%	11.2%	5.7%	$1.94
AMGN	Amgen Inc Manufacturing · Year ended 2025-12-31 · USD	$36.75B	$7.71B	21.0%	89.1%	10.0%	$14.23
HALO	Halozyme Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40B	$316.89M	22.7%	649.2%	37.6%	$2.56
ATRA	Atara Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$120.77M	$32.69M	27.1%	n/a	-6.3%	$2.57

Rows per page: 2550 100